Biofrontera Inc. Proceeds from Lines of Credit
Biofrontera Inc. (BFRI) reported Proceeds from Lines of Credit of $21.45 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2025-03-20
- Biofrontera Inc. proceeds from lines of credit for the quarter ending 2023-12-31 was $7.90M.
- Biofrontera Inc. proceeds from lines of credit for the quarter ending 2023-09-30 was $7.85M.
- Biofrontera Inc. proceeds from lines of credit for fiscal 2023 was $21.45M.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2023-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $15.75M derived: sum of 2 quarters · filed 2025-03-20 | $21.45M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $7.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $13.55M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $5.70M 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |